 random trial ticarcillin clavulan versu gentamicin clindamycin patient complic append secondari bacteri periton polymicrobi infect facult gram-neg aerob anaerob organ treatment oper broad-spectrum antibiot administr antibiot treatment choic infect combin gentamicin clindamycin combin toxic side effect necessit frequent monitor serum level beta-lactam antibiot broad-spectrum coverag low toxic speci bacteria beta-lactamas enzym clavulan acid potent inhibitor beta-lactamas efficaci ticarcillin enzym combin gentamicin clindamycin consecut patient complic append erad identifi pathogen ticarcillin clavulan group cent gentamicin clindamycin group cent subgroup organ beta-lactamas versu cent erad complic clinic respons differ treatment group ticarcillin clavulan acid safe effect altern treatment secondari bacteri periton advantag simplic freedom ototox nephrotox effect